Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Blake

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Molecular Graphics & Modelling|January 6, 2001
Visualizing substructural fingerprintsR D Clark, D E Patterson, F Soltanshahi, et al.
Journal of Pharmaceutical Sciences|April 3, 1999
Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl etherY Kim, D A Oksanen, W Massefski, et al.
Neuropharmacology|December 1, 1993
Antagonism of baclofen-induced depression of whole-cell synaptic currents in spinal dorsal horn neurones by the potent GABAB antagonist CGP55845J F Blake, C Q Cao, P M Headley, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel mu opioid receptor ligandsM P Allen, J F Blake, D K Bryce, et al.
Journal of Medicinal Chemistry|November 22, 1996
Glucose transport-enhancing and hypoglycemic activity of 2-methyl-2-phenoxy-3-phenylpropanoic acidsR Sarges, R F Hank, J F Blake, et al.
Journal of Medicinal Chemistry|May 18, 2001
Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tetherB L Chenard, W M Welch, J F Blake, et al.
Journal of Medicinal Chemistry|August 19, 1994
Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesteraseA Villalobos, J F Blake, C K Biggers, et al.
Journal of Medicinal Chemistry|July 6, 2000
Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffoldR P Robinson, E R Laird, J F Blake, et al.
Journal of Medicinal Chemistry|April 17, 1998
(3R,4S)-3-[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)- 1-propanolT W Butler, J F Blake, J Bordner, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocketL A Reiter, J P Rizzi, J Pandit, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Molecular Graphics & Modelling|January 6, 2001
Visualizing substructural fingerprintsR D Clark, D E Patterson, F Soltanshahi, et al.
Journal of Pharmaceutical Sciences|April 3, 1999
Inclusion complexation of ziprasidone mesylate with beta-cyclodextrin sulfobutyl etherY Kim, D A Oksanen, W Massefski, et al.
Neuropharmacology|December 1, 1993
Antagonism of baclofen-induced depression of whole-cell synaptic currents in spinal dorsal horn neurones by the potent GABAB antagonist CGP55845J F Blake, C Q Cao, P M Headley, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2000
Design, synthesis and biological evaluation of 3-amino-3-phenylpropionamide derivatives as novel mu opioid receptor ligandsM P Allen, J F Blake, D K Bryce, et al.
Journal of Medicinal Chemistry|November 22, 1996
Glucose transport-enhancing and hypoglycemic activity of 2-methyl-2-phenoxy-3-phenylpropanoic acidsR Sarges, R F Hank, J F Blake, et al.
Journal of Medicinal Chemistry|May 18, 2001
Quinazolin-4-one alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists: structure-activity relationship of the C-2 side chain tetherB L Chenard, W M Welch, J F Blake, et al.
Journal of Medicinal Chemistry|August 19, 1994
Novel benzisoxazole derivatives as potent and selective inhibitors of acetylcholinesteraseA Villalobos, J F Blake, C K Biggers, et al.
Journal of Medicinal Chemistry|July 6, 2000
Structure-based design and synthesis of a potent matrix metalloproteinase-13 inhibitor based on a pyrrolidinone scaffoldR P Robinson, E R Laird, J F Blake, et al.
Journal of Medicinal Chemistry|April 17, 1998
(3R,4S)-3-[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)- 1-propanolT W Butler, J F Blake, J Bordner, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Inhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocketL A Reiter, J P Rizzi, J Pandit, et al.
Pageof 2